Skip to main content
All lobbying filings

NOVAVAX, INC

Lobbying for NOVAVAX, INC

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $110,000.00 expenses · posted Jan 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Issues related to COVID-19 vaccines, federal vaccine programs, and vaccine regulatory frameworks

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem